Recent News

3D Printing and Optical Scanning Could Help Mesothelioma Treatment

September 25, 2026

New technologies offer hope for more effective treatments for malignant pleural mesothelioma and other hard-to-treat cancers. One innovation is the use of 3D printing and optical scanning. These new technologies[…]

Ipilimumab and Nivolumab Can Improve Survival in Mesothelioma Patients

September 18, 2026

Mesothelioma is a rare and tough cancer to treat and is usually linked to asbestos exposure. Scientists are continually exploring new ways to treat it, and one promising method is[…]

Mesothelin Could Be Used to Improve Mesothelioma Treatment

September 11, 2026

Mesothelioma is a hard cancer to treat and understand. Understanding protein expressed by mesothelioma cells could potentially help. This protein may be a clue to the cancer, but an easier[…]

Radiomics Can Be Used to Improve Mesothelioma Treatment

September 4, 2026

Malignant mesothelioma is a challenging cancer to treat. New therapies like T cell receptor fusion constructs (TRuCs) show promise. Identifying which patients will benefit from these treatments is important. Radiomics,[…]

Recurring Collapsed Lung Could Indicate Mesothelioma

August 28, 2026

A new article highlights the link between a collapsed lung and mesothelioma. Mesothelioma, caused by asbestos exposure, can present unexpectedly due to its long latency period. It often requires many[…]

A Type of T Cell Therapy is Showing Promising Results for Mesothelioma

August 21, 2026

A clinical trial testing a new type of cell therapy for mesothelioma is actively recruiting patients at sites across the country, including Moffitt Cancer Center in Tampa, Florida. The trial[…]

A New Guideline for Surgery has Been Created for Mesothelioma

August 14, 2026

A national panel of 15 mesothelioma specialists across surgery, medical oncology, radiation oncology, and pathology reached a consensus and issued new guidelines for surgery. The experts reviewed 116 studies and[…]

RSO-021 Controlled Mesothelioma in Two-Thirds of Patients in Study

August 7, 2026

A new mesothelioma drug controlled the disease in two out of three patients through 12 weeks of treatment. Researchers say it turns cancer’s own defenses against it. Teams at the[…]

Mesothelioma Cells are Able to Get Around Different Types of Treatment

July 31, 2026

Mesothelioma cells have a survival trick. When researchers exposed them to an experimental drug that targeted one of the cancer’s main growth switches, the cells did not die. Instead, they[…]

Targeting the Collagen Receptor uPARAP to Treat Mesothelioma

July 24, 2026

Mesothelioma, a cancer with low survival rates, is still a major problem. A major cause of the cancer is asbestos exposure. A new study focuses on a possible treatment target[…]

Skip to content